NCT06683482 A Qualitative Study on Advanced Breast Cancer Patients and Their Caregivers in Spain Status COMPLETED Phase N/A
NCT06678269 A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer Status RECRUITING Phase PHASE1
NCT06678230 Clinical Trial of Eribulin in Combination with Anrotinib for HER-2 Negative Locally Advanced or Metastatic Breast Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT06678048 Arsenous Acid for Refractory Triple-Negative Breast Cancer Status RECRUITING Phase PHASE2
NCT06677944 Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer Status RECRUITING Phase PHASE2
NCT06677879 A Prospective Cohort Study of Proton and Photon Therapy for Left-sided Breast Cancer. Status RECRUITING Phase PHASE2
NCT06673329 Brodalumab in the Treatment of Immune-Related Adverse Events Status RECRUITING Phase PHASE1
NCT06672497 Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients Status RECRUITING Phase N/A
NCT06671249 Comparing the Safety and Cosmetic Outcomes Between Laparoscopic Versus Traditional Open Breast-conserving Surgery Status NOT_YET_RECRUITING Phase NA
NCT06669910 Investıgatıon of Temporomandıbular Dysfunctıon in Patıents Wıth Breast Cancer-Related Lymphedema Status COMPLETED Phase N/A
NCT06666270 Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT06665178 Genomic and Transcriptomic Predictors of Sequential SG Sensitivity After T-DXd in ER+/HER2-Low Metastatic Breast Cancer Status RECRUITING Phase PHASE2
NCT06664892 Ultrahypofractionated Whole Breast Radiation Following Chemotherapy Status NOT_YET_RECRUITING Phase NA
NCT06663228 Rapid Histologic Assessment for Stereotactic Breast Biopsy: Enhancing Early Detection With Miniature Mass Spectrometry and AI Status RECRUITING Phase N/A
NCT06660628 Large Segmentation Radiotherapy ± Deep Inspiration Breath Hold(DIBH) for Left Breast Cancer Status RECRUITING Phase NA
NCT06655545 18F-fluoroestradiol (18F-FES) PET/CT Guided First-line Treatment for HR+/HER2- Metastatic Breast Cancer Patients Status COMPLETED Phase N/A